-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

642.P1.72 642. Chronic Lymphocytic Leukemia: Clinical and Epidemiological: Poster I

Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 11, 2021: 5:30 PM-7:30 PM
Hall B5, Level 1, Building B (Georgia World Congress Center)

John F. Seymour1, Jenny Qun Wu2*, Relja Popovic3, Barbara Eichhorst, MD4, Peter Hillmen5*, Thomas J. Kipps, MD, PhD6, Anton W. Langerak, Prof., PhD7*, Carolyn Owen, MD8, Julie Dubois9*, Clemens Mellink9*, Anne-Marie Van Der Kevie-Kersemaekers9*, Fengjiao Dunbar10*, Yanwen Jiang, PhD2*, Brenda Chyla, PhD10, Michelle Boyer11*, Maria Thadani-Mulero11*, Marcus Lefebure11*, Rosemary Harrup12* and Arnon P. Kater, MD, PhD9

1Royal Melbourne Hospital, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Australia
2Genentech, Inc., South San Francisco, CA
3AbbVie Inc., North Chicago, IL
4University of Cologne, Department I of Internal Medicine and Center of Integrated Oncology Aachen and German CLL Study Group, Cologne, Germany
5St. James's University Hospital, Leeds, United Kingdom
6UCSD Moores Cancer Center, San Diego, CA
7Erasmus MC, University Medical Center, Rotterdam, Netherlands
8University of Calgary, Calgary, Canada
9Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
10AbbVie, North Chicago, IL
11Roche Products Ltd., Welwyn Garden City, United Kingdom
12Royal Hobart Hospital, University of Tasmania, Tasmania, Australia

Chan Yoon Cheah1,2, Wojciech Jurczak, MD, PhD3*, Masa Lasica, MBBS4*, Tomasz Wróbel, MD, PhD5, Stanley Cheung, MBBS6*, Jan Walewski, MD7, Krzysztof Giannopoulos, MD, PhD8*, Costas K. Yannakou, MBBS FRACP FRCPA9*, Katharine L Lewis, MBBS1,2, Monika Dlugosz-Danecka, MD, PhD3*, Hari P. Miskin, MSc10, Alejandro D. Ricart, MD10*, Owen A. O'Connor, MD, PhD10* and Constantine S. Tam, MBBS, MD4*

1Medical School, University of Western Australia, Crawley, WA, Australia
2Department of Haematology, Linear Clinical Research and Sir Charles Gairdner Hospital, Nedlands, WA, Australia
3Maria Sklodowska-Curie National Research Institute of Oncology, Kraków, Poland
4St. Vincent Hospital and University of Melbourne, Melbourne, VIC, Australia
5Department of Hematology, Wroclaw Medical University, Wroclaw, Poland
6Ashford Cancer Centre Research, Adelaide, SA, Australia
7Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
8Hematology Department, St. John’s Cancer Centre, Lublin, Poland
9Department of Molecular Oncology and Cancer Immunology, Epworth HealthCare, East Melbourne, VIC, Australia
10TG Therapeutics, Inc., New York, NY

Nitin Jain, MD1, Alessandra Ferrajoli, MD2, Philip A. Thompson2, Marina Konopleva, MD, PhD2, Michael R Green, PhD3, Deepa Sampath, PhD4, Sattva S. Neelapu, MD5, Koichi Takahashi, MD, PhD6, Paolo Strati, MD7, Jan A. Burger, MD, PhD2, Rashmi Kanagal-Shamanna, MD8, Joseph D. Khoury9, Naveen Garg, MD10*, Xiaoping Su, PhD11*, Xuemei Wang, MS12*, Hinalben Patel, RN2*, Ana Ayala, RN2*, Hagop Kantarjian, MD2, Michael J. Keating, MBBS2 and William G. Wierda13

1Department of Leukemia, MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Hematopoietic Biology & Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Lymphoma and Myeloma, M.D. Anderson Cancer Center, Houston, TX
6Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
7Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
8Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX
9Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
10Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX
11Department of Bioinformatics & Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX
12Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
13Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX

Arnon P. Kater, MD, PhD1, Tong Lu2*, Anton W. Langerak, Prof., PhD3*, Clemens Mellink1*, Brenda Chyla, PhD4, Jenny Qun Wu2*, Michelle Boyer5*, Marcus Lefebure5*, Yanwen Jiang, PhD2* and John F. Seymour6

1Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
2Genentech, Inc., South San Francisco, CA
3Erasmus MC, University Medical Center, Rotterdam, Netherlands
4AbbVie, North Chicago, IL
5Roche Products Ltd., Welwyn Garden City, United Kingdom
6Royal Melbourne Hospital, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Australia

Florian Simon, MD1*, Adam Giza1*, Sandra Robrecht, PhD1*, Anna-Maria Fink, MD1*, Paula Cramer, MD1*, Julia Von Tresckow, MD1,2*, Moritz Fürstenau, MD1, Valentin Goede, MD1,3*, Eugen Tausch, MD4*, Christof Schneider, MD5*, Stephan Stilgenbauer, MD4, Clemens-Martin Wendtner, MD6, Barbara Eichhorst, MD1, Kirsten Fischer, MD1*, Michael Hallek, MD7 and Othman Al-Sawaf, MD1*

1Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Düsseldorf, German CLL Study Group, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany
2Clinic for Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Essen, Germany
3St. Marien Hospital, Oncogeriatric Unit, Department of Geriatric Medicine, Germany, Cologne, Germany
4Department III of Internal Medicine, Ulm University, Ulm, Germany
5Department of Internal Medicine III, Ulm University, Ulm, Germany
6Department of Hematology, Oncology, Immunology, Palliative Care, Infectious Diseases and Tropical Medicine, German CLL Study Group, Munich Clinic Schwabing, Munich, Germany
7University of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; Center for Molecular Medicine Cologne; CECAD Center of Excellence on Cellular Stress Responses in Aging-Associated Diseases, Cologne, Germany

Matthew S. Davids, MD1, Anthony R. Mato, MD2, Juliette Hum3*, Susana Wargo3*, Ugochinyere Emeribe4*, Mina Shahkarami5*, Kevin Sokolowski6*, Juliana M.L. Biondo7*, Sarang Abhyankar7*, Rick Hermann4* and Jeff P. Sharman, MD8

1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
2Memorial Sloan Kettering Cancer Center, New York, NY
3AstraZeneca, Mississauga, ON, Canada
4AstraZeneca, Gaithersburg, MD
5AstraZeneca, South San Francisco, CA
6AbbVie, North Chicago, IL
7Genentech Inc, South San Francisco, CA
8Willamette Valley Cancer Institute and US Oncology Research Center, Eugene, OR

Matthew S. Davids, MD1, Tanya Siddiqi, MD2*, Asher Chanan-Khan3*, Alan Skarbnik, MD4, Allison M. Winter5, John M. Pagel, MD, PhD6, Carrie Smith7*, Nashat Gabrail7*, Tetiana Perekhrestenko8*, Halyna Pylypenko9*, Olena Kyselova10*, Olena Karpenko10*, Tetiana Popovska11*, Iryna Kriachok12*, Hanna Usenko13*, Andrew Proidakov14*, Vladimir Ivanov15*, Tamila Lysa16*, Elena Borisenkova17*, Bulat Bakirov18*, Les Lukavetsky19*, Olga Uspenskaya20*, Tatiana S. Konstantinova21*, Olga S. Samoylova22*, Zi Chen23*, Bo Huang23*, Mingyu Li24*, Mohammad Ahmad24*, Boyd Mudenda24*, Dajun Yang23,25* and Yifan Zhai23,24

1Department of Medical Oncology, Dana-farber/Boston Children's Cancer and Blood Disorders Ctr, Boston, MA
2Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
3Hematology/Oncology, Mayo Clinic, Jacksonville, FL
4Novant Health Cancer Institute, Charlotte, NC
5Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
6Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, WA
7Gabrail Cancer Center, Canton, OH
8Medical Center of Yurii Spizhenko LLC, Kiev, Ukraine
9Regional Treatment and Diagnostics Haematology Centre, Cherkassy Regional Council, Cherkassy, Ukraine
10Medical Center “Ok!Clinic+” of International Institute of Clinical Research LLC, Kiev, Ukraine
11Grygoriev Institute of Radiology of the NAoMS of Ukraine, Kharkiv, Ukraine
12Department of Chemotherapy of Hemoblastoses of Division of Conservative Methods of Treatment, Kiev, Ukraine
13Dnipropetrovsk Regional Hematology Center, Dnipropetrovsk CCH #4, Dnipro, Ukraine
14State Institution Komi Republican Oncological Dispensary, Krasnozatonsky, Russian Federation
15National Medical Research Center Named after B Almazov, St.Petersburg, Russian Federation
16Regional Clinical Hospital n. a. O. F. Herbachevskyi, Zhytomyr, Russian Federation
17Regional Clinical Hospital, Kaluga, Russian Federation
18Bashkir State Medical University, Ufa, Russian Federation
19Hematology Department, Institute of Blood Pathology and Transfusion Medicine of NAoMS of Ukraine, Lviv, Ukraine
20Leningrad Regional Clinical Hospital Saint-Petersburg, St. Petersburg, Russian Federation
21Regional Clinical Hospital No 1, Ekaterinburg, Russian Federation
22Nizhny Novgorod Regional Clinical Hospital, Named after N. A. Semashko, Nizhniy Novgorod, Russian Federation
23Ascentage Pharma (Suzhou) Co., Ltd., Suzhou, China
24Ascentage Pharma Group Inc., Rockville, MD
25Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangzhou, China

Andrew H. Lipsky, MD1, Brian T. Hill, MD2, Allison M. Winter3, Joseph G. Jurcic, MD1, Mark L. Heaney, MD1, Todd L. Rosenblat, MD, MS1*, Matthew Chiaramonte, BA1*, Hanna Weissbrot, BA1* and Nicole Lamanna, MD4

1Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY
2Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, OH
3Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
4Columbia University Medical Center, New York-Presbyterian/Columbia University Medical Center, New York, NY

Christopher Pleyer, MD1, Kerry J Laing, PhD2*, Mir Ali, PhD3*, Christopher L McClurkan2*, Susan Soto4*, Inhye E. Ahn, MD5, Pia Nierman, BSN, MA, RN4*, Emeline Maddux4*, Jennifer Lotter, PA-C4*, Jeanine Superata, RN4*, Xin Tian, PhD6*, Erika M Gaglione4*, Adrian Wiestner, MD, PhD4*, Jeffrey Cohen, MD3*, David M Koelle, MD2* and Clare Sun, MD7

1Hematology Branch, National Institutes of Health Clinical Center, Bethesda, MD
2Department of Medicine, University of Washington, Seattle, WA
3Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
4Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
5Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
6Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
7Hematology Branch, National Heart, Lung and Blood Institute, Bethesda, MD

Ashley Matuszfisher, MD1, Rupali Bose, MS, MBA2*, Danielle Boselli, MS2*, Gray Magee3*, Tommy Chen, BS2*, Bei Hu, MD1, Tamara K. Moyo, MD, PhD1*, Amy Soni, MD1, Steven I. Park, MD1, Edward A. Copelan, MD1, Belinda Avalos, MD1*, James T Symanowski, PhD2*, Derek Raghavan, MD, PhD, FACP, FRACP4*, Ryan Jacobs, MD1* and Nilanjan Ghosh, MD, PhD1

1Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
2Department of Cancer Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, NC
3Internal Medicine, Atrium Health, Carolinas Medical Center, Charlotte, NC
4Levine Cancer Institute, Atrium Health, Charlotte, NC

Siba El Hussein, MD1,2*, Pingjun Chen, PhD3*, L. Jeffrey Medeiros, MD2, Jia Wu, PhD3* and Joseph D. Khoury2

1Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY
2Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX

Timothy W. Smith1*, Henry F. Owusu, PhD2*, David Wormser, PhD3* and Janghee Woo, MD, PhD4

1Novartis Pharmaceuticals Corporation, East Hanover, NJ
2Novartis Pharmaceuticals Corporation, Basel, Switzerland
3Novartis Pharma AG, Basel, Switzerland
4Oncology Translational Research, Novartis Institutes for BioMedical Research, Cambridge, MA

Paul J. Hampel, MD1, Kari G. Rabe, MS2*, Timothy G. Call, MD3, Wei Ding, MD, PhD1, Jose F. Leis, MD, PhD4, Asher Chanan-Khan, MBBS, MD5, Saad S. Kenderian, MD1, Eli Muchtar, MD1, Yucai Wang, MD, PhD1, Sikander Ailawadhi, MD6, Amber Koehler, PA-C1*, Susan M. Schwager1*, Taimur Sher, MD7, Curtis A. Hanson, MD8, Min Shi, MD, PhD8, Daniel L. Van Dyke, PhD8, Esteban Braggio, PhD9, Susan L. Slager, PhD10,11, Neil E. Kay, MD3 and Sameer A. Parikh, MD3

1Division of Hematology, Mayo Clinic, Rochester, MN
2Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN
3Hematology, Mayo Clinic, Rochester, MN
4Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic Arizona, Phoenix, AZ
5Division of Hematology, Mayo Clinic, Jacksonville, FL
6Division of hematology, Mayo Clinic, Jacksonville, FL
7Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
8Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
9Hematology/Oncology, Mayo Clinic, Phoenix, AZ
10Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
11Computational Biology, Mayo Clinic, Rochester, MN

Patricia Baltasar, MD1*, María José Terol, MD PhD2*, Juan Marquet Palomanes, MD3*, Angel Ramírez Payer, MD4*, Carol Moreno, MD, PhD5*, Santiago Osorio, MD6*, Fátima De la Cruz, MD7*, Jose A. Garcia-Marco Sr., MD, PhD8, Macarena Ortiz, MD9*, Eduardo Ríos Herranz, MD10*, Laura Magnano, MD11*, Sandra Iraheta, MD12*, Jose Manuel Puerta, MD13*, Javier de la Serna, MD14*, Alicia Smucler Simonovich, MD15*, Jose Maria Arguiñano, MD16*, Javier Loscertales, MD17*, Begoña Muiña, MD18*, Ruben Fernandez, MD19*, Tomas García, MD, PhD20*, José A. Márquez, MD21*, Ana Muntañola Prat, MD22*, Ernesto Pérez Persona, MD23*, Lucrecia Yáñez, MD, PhD24*, Manuel Pérez-Encinas, MD25*, Marcos González Díaz, MD26*, Gonzalo Caballero, MD27*, María Angeles Andreu, MD, PhD28*, Rafael Andreu, MD29*, Ana Ruiz-Zorrilla, MD30*, Diana Moreno31* and Christelle Ferrà, MD32*

1Hospital Universitario La Paz, Madrid, Spain
2Department of Hematology, Hospital Clínico Universitario de Valencia, INCLIVA, Valencia, Spain
3Hematology Service, Hospital Universitario Ramón y Cajal, Madrid, 28012, Spain
4Hospital Universitario Central de Asturias, Oviedo, Spain
5Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain
6Hospital General U. Gregorio Marañón, Madrid, Spain
7Hospital Universitario Virgen del Rocío, Sevilla, Spain
8Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain
9Hospital Regional Universitario Carlos Haya, Malaga, Spain
10Hospital Universitario Virgen de Valme, Sevilla, Spain
11Hospital Clínic, Universitat de Barcelona, Barcelona, Spain
12Hospital Universitario de Canarias, La Laguna, Tenerife, Spain
13Hospital Universitario Virgen de las Nieves, Granada, Spain
14Hospital Universitario 12 de Octubre, Madrid, Spain
15Hospital del Bierzo, León, Spain
16Complejo Hospitalario de Navarra, Pamplona, Spain
17Hospital Universitario de La Princesa, Madrid, Spain
18Hospital General Universitario Rafael Méndez, Lorca, Spain
19Hospital Universitario de Cabueñes, Gijón, Spain
20Hospital Arnau de Vilanova, LLeida, Spain
21Hospital Universitario de Basurto, Bilbao, Spain
22Hospital Mutua de Terrassa, Terrassa, Barcelona, Spain
23Hospital Universitario de Araba, Vitoria-Gasteiz, Spain
24Hospital Universitario Marqués de Valdecilla, Santander, Spain
25Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain
26Hospital Universitario de Salamanca, Salamanca, Spain
27Hematology, Hospital Universitario Miguel Servet, Zaragoza, Spain
28Hospital Universitario de Móstoles, Madrid, MADRID, Spain
29Hospital Universitario La Fe, VALENCIA, Spain
30Abbvie Spain, Departamento Médico Abbvie Spain, S.L.U., MADRID, Spain
31Departamento Médico Abbvie Spain, Madrid, Spain
32Institut Català d´Oncologia-H. Germans Trias i Pujol, Badalona, Spain

Priyanka A Pophali, MD1, Xin Victoria Wang, PhD2*, Fengmin Zhao, MS, MHS, PhD2*, Neil E. Kay, MD3, Curtis A. Hanson, MD4,5, Mary L. Thomas, RN, MS, AOCN6*, Susan M. O'Brien, MD7, Jacqueline Barrientos, MD, MS8, Elisabeth M. Paietta, PhD9*, Jose F. Leis, MD, PhD10, Cong Christine Zhang, MD, PhD11*, Steven Coutre, MD12, Paul M. Barr, MD13, Amanda Cashen, MD14*, Anthony R. Mato, MD15, Avina Singh, MD16*, Richard F. Little, MD, MPH17, Harry P. Erba, MD, PhD18, Richard M. Stone, MD19, Mark R. Litzow, MD4, Martin S. Tallman, MD15, Tait Shanafelt, MD12 and Lynne I. Wagner, PhD20*

1Division of Hematology, Department of Medicine, University of Wisconsin- Carbone Cancer Center, Madison, WI
2Dana-Farber Cancer Institute—ECOG-ACRIN Biostatistics Center, Boston, MA
3Hematology, Mayo Clinic, Rochester, MN
4Mayo Clinic, Rochester, MN
5Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
6VA, Palo Alto, CA
7University of California Irvine Health Cancer Center-Newport, Orange, CA
8Northwell Health Cancer Institute, New Hyde Park, NY
9Montefiore Medical Center, Bronx, NY
10Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
11Kaiser Permanente, Fresno, CA
12Stanford Cancer Institute, Palo Alto, CA
13University of Rochester, Rochester, NY
14Washington University School of Medicine, Saint Louis, MO
15Memorial Sloan Kettering Cancer Center, New York, NY
16Metro Minnesota Community Oncology Resesearch Consortium, Saint Louis Park, MN
17National Cancer Institute, Rockville, MD
18Duke University Medical Center, Duke Cancer Institute, Durham, NC
19Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
20Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, NC

Cecelia Miller, PhD1*, Ying Huang, MS, MA2*, Jonathan Hyak, MD3*, Matthew R Avenarius, PhD3*, Amy S. Ruppert, PhD2, John C. Byrd, MD4, Seema A Bhat, MD2, Michael R Grever, MD2, Adam S Kittai, MD2, Kerry Rogers, MD3, Nyla A. Heerema, PhD1, Lynne V. Abruzzo, MD, PhD1 and Jennifer A. Woyach, MD3

1Department of Pathology, The Ohio State University, Columbus, OH
2Division of Hematology, The Ohio State University, Columbus, OH
3The Ohio State University, Columbus, OH
4Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH

María José Terol, MD PhD1,2*, Alicia Serrano2,3*, Blanca Ferrer Lores2,3*, Francesc Bosch2,4, Marcos Gonzalez Diaz2,5*, Marta Crespo2,4, Miguel Alcoceba2,5*, Azahara Fuentes1*, Javier F Chaves1*, Lucia Esteve6*, Cristina Loriente6* and Miguel Villanueva, MD6

1Department of Hematology, University Clinic Hospital of Valencia, INCLIVA (Health Research Institute), University of Valencia, Valencia, Spain
2Spanish CLL Study Group, Madrid, Spain
3Department of Hematology, University Clinic Hospital of Valencia, Valencia, Spain
4Hematology Service, Vall d’Hebron University Hospital, Barcelona, Spain
5Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC (CB16/12/00233) and Cancer Research Center -IBMCC (USAL-CSIC), Salamanca, Spain
6Medical Department. Janssen Spain, Madrid, Spain

Guilherme Sacchi De Camargo Correia, MD1, Brandon S. Imber, MD2, Carla Hajj, MD3*, Meghan C. Thompson, MD4, Anthony R. Mato, MD5, Joachim Yahalom, MD4 and Lindsey E. Roeker, MD5

1Department of Medicine, Icahn School of Medicine at Mount Sinai Morningside and West, New York, NY
2Department of Radiation Oncology, David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
4Memorial Sloan Kettering Cancer Center, New York, NY
5CLL Program, Leukemia Service, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY

*signifies non-member of ASH